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Abstract
 
Transforming growth factor (TGF)-
 
 
 
 inhibits T cell proliferation and differentiation. TGF-
 
 
 
has been shown to inhibit the expression of transcription factors such as GATA-3 and T-bet
that play important roles in T cell differentiation. Here we show that TGF-
 
 
 
 inhibits T cell
differentiation at a more proximal step. An early event during T cell activation is increased in-
tracellular calcium levels. Calcium influx in activated T cells and the subsequent activation of
transcription factors such as NFATc, events essential for T cell differentiation, are modulated
by the Tec kinases that are downstream of the T cell receptor and CD28. We show that in
stimulated CD4
 
 
 
 T cells, TGF-
 
 
 
 inhibits phosphorylation and activation of the Tec kinase Itk,
increase in intracellular Ca
 
2
 
 
 
 levels, NFATc translocation, and activation of the mitogen-acti-
vated protein kinase ERK that together regulate T cell differentiation. Our studies suggest that
by inhibiting Itk, and consequently Ca
 
2
 
 
 
 influx, TGF-
 
 
 
 limits T cell differentiation along both
the Th1 and Th2 lineages.
Key words: TGF-
 
  
 
•
 
 
 
T cell • NFAT • Itk • calcium
 
Introduction
 
TGF-
 
 
 
 inhibits the function of macrophages, T cells, B
cells, and NK cells (1). Mice deficient in TGF-
 
 
 
 have been
shown to develop multi-organ inflammatory immune infil-
trate at the age of 2–3 wk (2). Also, it has been shown that
TGF-
 
 
 
 signaling is critical for controlling T cell homeosta-
sis as well as T cell differentiation by using transgenic mice
which express a dominant-negative TGF-
 
 
 
 receptor type 2
under a T cell–specific promoter (3). The major effect of
TGF-
 
 
 
 on mature T cells was though to be at the level of
inhibition of T cell proliferation and IL-2 production (4).
But it has been reported that TGF- 
 
 
 
 can interfere with T
cell polarization even under conditions in which T cell
proliferation is normal (5).
Because of its potent immunoinhibitory effects, some
studies have focused on the role of TGF-
 
 
 
 on allergic air-
way inflammation (6, 7). Transfer of antigen-specific
CD4
 
 
 
 T cells expressing latent TGF-
 
 
 
 into mice resulted
in profound inhibition of Th2-induced airway inflamma-
tion and airway hyperreactivity (7). Conversely, in another
study, overexpression of Smad7, an intracellular antagonist
of TGF-
 
 
 
 signaling, resulted in enhanced airway reactivity
and inflammation (8). These studies strongly suggest a po-
tential regulatory role of TGF-
 
 
 
 in asthma. Asthma has
been characterized as a Th2-mediated airway inflammation
(9). Several molecules are now known to be essential for
Th2 differentiation including STAT6, c-Maf, NFATc, and
GATA-3 (9–11). Recently, we demonstrated that by regu-
lating GATA-3 expression, nuclear factor (NF)
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plays a critical role in Th2 differentiation (12). The activa-
tion of these factors appears to be regulated by signaling
through TCR, costimulatory molecules, and the IL-4 re-
ceptor (10, 13, 14), indicating the requirement for multiple
signaling events for efficient Th2 differentiation. T cell dif-
ferentiation along the Th1 lineage is similarly regulated by
specific transcription factors, among which T-bet, ex-
pressed in a lineage-specific fashion, plays an essential role
in IFN-
 
 
 
 production (15, 16). Although it is well recog-
nized that TGF-
 
 
 
 suppresses T cell–mediated immune re-
sponses, whether TGF-
 
 
 
 targets upstream pathways that
prime for T cell differentiation along either lineage, has not
been investigated. Here, we show that TGF-
 
 
 
 can interfere
with critical upstream signaling events such as Tec kinase
phosphorylation and Ca
 
2
 
 
 
 mobilization that are critical for
T cell differentiation.
 
Materials and Methods
 
Antibodies and Reagents.
 
Anti-CD28 (37.51), anti-CD3
 
 
 
 (145–
2C11) were purchased from BD Biosciences. Anti-STAT6, anti-
GATA-3, anti-NFATc1, anti Txk (Rlk), anti-Oct-1, and anti-
CREB-1 were obtained from Santa Cruz Biotechnology, Inc.
Anti-Itk (2F12, monoclonal antibody), anti-Itk (rabbit poly-
clonal), and anti-phosphotyrosine (4G10) were purchased from
Upstate Biotechnology. Anti-phospho-ZAP-70, anti-ZAP-70,
anti-phospho-Lck, anti-Lck, anti-phospho–extracellular signal–
regulated kinase (ERK), anti-ERK, anti-phospho-JNK, anti-
JNK, and anti-phospho-GSK-3 were purchased from Cell
Signaling. The rabbit anti-murine Rlk antiserum used to immu-
noprecipitate Rlk was provided by Dr. Pamela Schwartzberg
(National Institutes of Health, Bethesda, MD) and its specificity
described previously (17). Rabbit anti–mouse antibody was ob-
tained from Sigma-Aldrich and goat anti–mouse from Jackson
ImmunoResearch Laboratories. Anti-T-bet antibody was pro-
vided by Dr. Laurie Glimcher (Harvard School of Public Health,
Boston, MA).
 
Cytokine Assays.
 
Cytokine concentrations were measured by
ELISA using commercially available kits: IL-2, and IL-5 (En-
dogen), IL-13, IL-4, and IFN-
 
 
 
 (R&D Systems). For intracellular
cytokine staining, purified spleen CD4
 
 
 
 T cells were stimulated
with plate-bound anti-CD3 and anti-CD28 for 72 h. After
blocking of Fc receptors with excess mouse Fc Block™ (2.4G2),
10
 
6
 
 CD4
 
 
 
 T cells were cell surface stained with Peridinin
Chlorophyll-a Protein-anti–mouse CD4 (RM4–5). Fixation and
permeabilization was done using reagents from the Cytofix-
Cytoperm Plus kit with the Golgi-plug protocol. Allophycocya-
nin-anti–mouse IL-4 (11B11) and Phycoerythrin-anti–mouse IL-5
(TRFK-5) were added to permeabilized cells (30 min on ice) for
the staining of cytoplasmic IL-4 and IL-5, respectively. Samples
were analyzed by flow cytometry using FACSCalibur™ and
CELLQuest™ software (BD Biosciences) and the frequency of
cytokine-positive cells was obtained by subtracting the value ob-
tained with the respective isotype controls. All antibodies and re-
agents were purchased from BD Biosciences.
 
Preparation of Nuclear Extracts, Immunoblot Analysis, and Electro-
phoretic Mobility Shift Assay.
 
CD4
 
 
 
 T cells were stimulated with
immobilized anti-CD3 (1 
 
 
 
g/ml) and anti-CD28 (1 
 
 
 
g/ml) and
IL-2 (50 U/ml) in the presence of IL-4 (200 U/ml; Becton
Dickinson) and anti–IFN-
 
 
 
 (XMG1.2) for Th2 differentiation
or IL-12 (5 ng/ml; R&D Systems) and anti–IL-4 (4 
 
 
 
g/ml; Bec-
 
ton Dickinson) for Th1 differentiation with or without of
TGF-
 
 
 
 (50 pM). Nuclear extracts were prepared at the indicated
time points and used for electrophoretic mobility shift assay
(EMSA) or Western blot analysis essentially as described previ-
ously (12, 18–20).
 
Retroviral Infections of Primary Murine CD4
 
 
 
 T Cells.
 
The ret-
roviral plasmid construct pMSCV-caNFATC1-H-2K
 
k
 
 (caNFATc1),
and methods for retrovirus production and infection have been
described previously (21). CD4
 
 
 
 T cells were stimulated under
neutral conditions with anti-CD3 and anti-CD28 and infected
at 24 and 48 h after activation by centrifugation at 2,000 rpm for
1.5 h at room temperature with 1.5 ml viral supernatants (con-
taining 6 
 
 
 
g/ml polybrene [Sigma-Aldrich] and 10 
 
 
 
g/ml
mIL-2). The viral supernatant was removed after the spin infec-
tion and replaced with medium containing 10 
 
 
 
g/ml murine
IL-2. The expression of green fluorescent protein (GFP) in in-
fected CD4
 
 
 
 T cells was determined by FACS
 
®
 
 analysis and
over 40% of the cells were found to be infected. The infected
CD4
 
 
 
 T cells were then restimulated under Th2 conditions in
the presence or absence of TGF-
 
 
 
. Nuclear extracts were pre-
pared after 5 d of culture as described previously and culture su-
pernatants were used for cytokine estimation (12, 18, 19).
 
In Vitro Kinase Assays.
 
The Itk kinase assay was performed as
described previously (22, 23) with minor modifications. Itk im-
munocomplexes were washed twice in kinase buffer (Cell Signal-
ing) and then incubated in 45 
 
 
 
l of kinase buffer containing 10
 
 
 
Ci of [
 
 
 
-
 
32
 
P] ATP (NEN Life Science Products), 10 
 
 
 
M ATP
and 5 
 
 
 
g of a peptide (Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-
Ala-Ala-Arg-Gly; Sigma-Aldrich) derived from the sequence sur-
rounding the SRC tyrosine kinase autophosphorylation site. This
mixture was incubated for 15 min at room temperature and the
reaction was stopped by adding 30% glacial acetic acid. The mix-
ture was then blotted onto phosphocellulose paper and washed 6
times with 1% phosphoric acid. The amount of 
 
 
 
32
 
P incorpo-
rated into the peptide was determined by scintillation counting.
To immunoprecipitate Rlk, equivalent amounts of whole cell
protein were incubated with the rabbit anti-rlk serum for 2 to 4 h
at 4
 
 
 
C. The complexes were recovered with protein A-Sepharose
(Amersham Biosciences), washed two times with ice cold lysis
buffer, and analyzed by Western blotting with the goat anti-rlk
antibody (Santa Cruz Biotechnology, Inc.). Rlk kinase assay was
performed as described previously using 20 
 
 
 
Ci of [
 
 
 
-
 
32
 
P] ATP
(NEN Life Science Products) and 10 
 
 
 
M ATP and incubating
for 15 min at room temperature.(17).
 
Measurement of Intracellular Calcium Concentration by Micros-
copy.
 
Chambered glass coverslips were washed and first coated
with poly 
 
l
 
-lysine and next with anti-CD3 and anti-CD28 (1
 
 
 
g/ml). The coverslips were extensively washed, covered with
a thin layer of PBS and stored at 4
 
 
 
C for up to 1 wk before use.
Purified CD4
 
 
 
 T cells were loaded with 2 
 
 
 
M Fura2-AM (Mo-
lecular Probes) for 30 min at 37
 
 
 
C in serum free medium. The
cells were next washed and suspended in HEPES buffered
media for imaging. Coverslips coated with antibodies were
mounted in a Harvard Systems culture chamber and heated to
37
 
 
 
C. Using a 40
 
 
 
 dry High NA objective (0.95), and an
Olympus automated microscope, driven by Simple PCI, the
upper surface of the coverslip was found and focused. Cells
were added to the chamber, and images collected every 10 s us-
ing motorized excitation filters at 340 and 380 nm, emission at
510 nm and an Orca 100 camera. The total imaging period for
each experiment was 10 min. Using Simple PCI, ratios were
calculated for the 340/380 spectra and corrected for background
fluorescence.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
1691
 
Chen et al.
 
Measurement of Intracellular Ca
 
2
 
 
 
 Concentration ([Ca
 
2
 
 
 
]i) by Flow
Cytometry.
 
The Ca
 
2
 
 
 
 flux in CD4
 
 
 
 T cells was examined using
Fluo 3-AM essentially as described previously (24). Purified
CD4
 
 
 
 T cells were loaded with Fluo 3-AM by incubation for 30
min at room temperature with 3 
 
 
 
M Fluo 3-AM in the presence
of 0.01% pluronic F-127 in HBSS supplemented with 1% FCS.
Loaded CD4
 
 
 
 T cells were washed 4 times and resuspended in a
Hepes-buffered saline solution containing 137 mM NaCl, 5 mM
KCl, 1 mM Na
 
2
 
HPO4, 5 mM glucose, 1 mM CaCl
 
2
 
, 0.5 mM
MgCl
 
2
 
, BSA 1 mg/ml, Hepes 10 mM, pH 7.4. The cells were
then activated with 5 
 
 
 
g each of anti-CD3 and anti-CD28 in
HEPES-buffered saline solution for 15 min on ice. The anti-
body-bound cells were washed and subjected to Ca
 
2
 
 
 
 flux analy-
sis by flow cytometry for 90 s at 37
 
 
 
C. Next prewarmed HEPES-
buffered saline solution containing 20 
 
 
 
g/ml rabbit anti-mouse
was added with or without TGF-
 
 
 
. [Ca
 
2
 
 
 
]i was monitored for
the next 600 s at 37
 
 
 
C and results were analyzed by
CELLQuest™.
 
Online Supplemental Material.
 
Videos included as online sup-
plemental material show Ca
 
2
 
 
 
 flux in real time in CD4
 
  T cells
maintained with or without TGF- . Images were collected
every 10 s for a total of 10 min. Online supplemental mate-
rial is available at http://www.jem.org/cgi/content/full/jem.
20021170/DC1. 
Results
Impaired Th2 Polarization in the Presence of TGF- . We
first investigated whether we could set up conditions in
which the effect of TGF-  on cell proliferation could be
dissociated from its effects on T cell differentiation. To-
ward this end, we stimulated CD4  T cells from OVA
TCR transgenic mice with antigen (Ag; pOVA323–339) in
the presence of various doses of TGF- . Cell proliferation
was measured by [3H]thymidine incorporation and IL-2
production was examined. Fig. 1 A shows dose-dependent
inhibition of cell proliferation by TGF- . TGF-  affected
IL-2 production even at the lowest dose of 10 pM (Fig. 1
A, top panel). However, when IL-2 (50 U/ml) was pro-
vided in culture, T cell proliferation was sustained even at a
dose of 100 pM of TGF-  (Fig. 1 A, bottom panel). As a
dose of 50 pM TGF-  did not interfere with cell prolifera-
tion in the presence of exogenously added IL-2, we used
this dose in subsequent experiments to investigate its effects
on T cell differentiation.
We next investigated the effects of TGF-  on Th2 dif-
ferentiation to identify proximal targets during T cell dif-
ferentiation. CD4  T cells were primed under Th2 condi-
tions with Ag and APCs in the presence or absence of
TGF-  for 5 d. Cells were then harvested and restimulated
for 48 h and Th2 cytokine production was measured. A
significant decrease in Th2 cytokine production was ob-
served in the presence of TGF-  (Fig. 1 B). These results
indicate that TGF-  not only exerts antiproliferative effects
on T cells, but even when conditions are conducive to
proliferation in the presence of IL-2 in the microenviron-
ment, TGF-  is able to inhibit T cell differentiation. When
CD4  T cells are stimulated to differentiate, several
transcription factors important for Th2 differentiation are
activated through phosphorylation or dephosphorylation
events which ultimately result in the presence of transcrip-
tionally competent factors inside the nucleus (11, 25, 26).
We next examined whether TGF-  affected the nuclear
presence of these factors. Consistent with the finding of
other groups (27, 28), TGF-  did not affect nuclear trans-
location of STAT6 even after incubation with TGF-  for
5 d. However, the transcription factors NFATc and
GATA-3 could be barely detected in the nuclear fraction
prepared from TGF- –treated cells (Fig. 1 C). These re-
sults suggested that TGF-  spares IL-4 receptor-mediated
signaling and probably targets TCR/CD28-signaling.
Figure 1. Inhibition of Th2 differentiation by TGF- . (A) CD4  T
cells from DO11.10 TCR transgenic mice were stimulated with
pOVA323–339 (5  g/ml) and splenic APCs under Th2 differentiating con-
ditions with or without rIL-2 (50 U/ml)   TGF-  at different concen-
trations. On day 3 after stimulation, cells were pulsed with [3H]thymidine
and incorporation was measured. The background was subtracted from
the results and results were expressed as percent change from baseline. (B)
CD4  T cells from DO11.10 mice were stimulated with pOVA323–339 (5
 g/ml) and splenic APCs under Th2 differentiating conditions with or
without pOVA323–339 (5  g/ml) and   TGF-  (50 pM). After 5 d, cells
were harvested and restimulated at equivalent cell numbers. Supernatants
were harvested after 48 h and assayed for the production of IL-5 and IL-13.
(C) Nuclear extracts prepared from CD4  T cells stimulated in the pres-
ence or absence of TGF-  during Th2 differentiation were analyzed by
immunoblotting with antibodies to STAT6, NFATc, and GATA-3.T
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TGF-  Does Not Inhibit NF- B Activation but Impairs
NFATc Translocation and GATA-3 Expression. The series
of experiments described next were performed to deter-
mine the effects of TGF-  during primary stimulation of
CD4  T cells under Th2-differentiating conditions. As
shown in Fig. 2 A, TGF-  inhibited Th2-type cytokine
production during primary stimulation of cells using a
combination of anti-CD3/anti-CD28. Recently, we have
shown that TCR-induced NF- B activation is essential for
GATA-3 expression and in turn Th2 differentiation (12).
Because our data suggested that TGF-  may interfere with
TCR signaling, we asked whether TGF-  interfered with
the activation of NF- B. As shown in Fig. 2 B, there was
essentially no effect of TGF-  on NF- B activation as
measured by EMSA.
NFATc is known to be an important regulator of IL-4
production and thus of Th2 differentiation (29, 30). In rest-
ing cells, NFATc resides in the cytoplasm as a phosphory-
lated protein. Upon stimulation, NFATc undergoes de-
phosphorylation by the calcium-dependent phosphatase
calcineurin, which allows it to translocate to the nucleus to
induce gene transcription (31, 32). The dephosphorylation
of NFATc by calcineurin is inhibited by cyclosporin A
(CsA). As shown in Fig. 2 C, treating cells with CsA not
only inhibited the nuclear translocation of NFATc, but the
up-regulation of GATA-3 expression in stimulated cells
was also compromised despite the presence of exogenously
added IL-4. It is to be noted that the basal low level of
GATA-3 expression that is typically observed in CD4 
T cells was not affected by either CsA or TGF-  but only
the induced expression was inhibited by both reagents. A
direct effect of calcineurin on GATA-3 is unlikely as, un-
like NFATc, GATA-3 resides in the nucleus in nuclear
bodies in unstimulated cells (33) and undergoes phosphory-
lation and not dephosphorylation upon stimulation of cells,
as we recently demonstrated (34). These results suggest a
potential role for NFATc in the expression of GATA-3
which may be direct or indirect through regulation of
other NFATc-dependent transcription factors. The early
induction of NFATc during Th2 differentiation and its es-
sential role in IL-4 gene expression together with the inhi-
bition of GATA-3 expression by CsA prompted us to ex-
plore effects of TGF-  on TCR/CD28-induced proximal
pathways that are linked to NFATc activation.
The effects of TGF-  on NFATc could be either on
suppression of NFATc expression or on inhibition of
NFATc translocation. As shown in Fig. 3 A, CD4  T cells
stimulated by a combination of anti-CD3 and anti-CD28
under Th2-differentiating conditions displayed a net in-
crease in NFATc levels which was not inhibited by either
TGF-  or CsA as determined by immunoblotting of
whole cell lysates. There are three splice variants of
NFATc and the slightly slower migration pattern of the
bands in TGF- – and CsA-treated cultures reflects inhibi-
tion of dephosphorylation of NFATc that is normally ef-
fected by calcineurin. These observations showed that al-
though TGF- , like CsA, inhibits processing of NFATc, it
does not interfere with net NFATc accumulation in the
Figure 2. NFATc, and not NF- B, is the target of TGF-  during Th2
differentiation. (A) CD4  T cells were stimulated with anti-CD3 and
anti-CD28 under Th2 differentiating conditions with or without the ad-
dition of TGF-  (50 pM). After 72 h incubation, the cells were harvested
and stained for the simultaneous expression of cell-surface CD4, and in-
tracellular IL-4 and IL-5. Flow cytometry was performed with 50,000
gated events collected for analysis of each sample. Appropriate isotype
controls were included for each antibody. Cells in the lymphoid gate
consisted of  98% CD4  cells in all experimental groups. Compared
with controls stimulated with anti-CD3   anti-CD28 alone, TGF-  in-
hibited intracellular expression of both cytokines: 0.76% versus 0.11% of
CD4  cells for IL-4, and 0.38% versus 0.04% of CD4  cells for IL-5, re-
spectively. (B) To determine the effects on NF- B activation, cells were
stimulated in the presence or absence of TGF-  for 3 h. Nuclear extracts
were prepared and analyzed for NF- B activation by EMSA. (C) TGF- 
and CsA both inhibit NFATc translocation as well as up-regulation of
GATA-3 expression during Th2 differentiation. CD4  T cells were stim-
ulated with anti-CD3 and anti-CD28 under Th2- differentiating condi-
tions with or without TGF-  (50 pM) or cyclosporin A (100 ng/ml).
Nuclear extracts were prepared and analyzed for the presence of NFATc
and GATA-3. It is to be noted that induced, but not basal, expression of
GATA-3 is inhibited by CsA and TGF- .T
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cell. In a recent study, Feske et al. showed that the dura-
tion of nuclear presence of NFAT influences the pattern of
expression of several cytokines in human T cells (35). This
observation led us to suspect that TGF-  may interfere
with the nuclear residence of NFATc either by inhibiting
its import (by suppressing dephosphorylation) or by expe-
diting its export (by enhancing rephosphorylation). To in-
vestigate this, we used the drug leptomycin B (LMB),
which inhibits Crm-1–mediated export of NFATc causing
accumulation of NFATc in the nucleus (36). Thus, if
TGF-  interfered with NFATc import, LMB would be
unable to cause nuclear accumulation of NFATc. On the
other hand, if TGF-  did not interfere with import of
NFATc but only expedited its export, similar levels of
NFATc should be observed in control and TGF- -treated
cells in the presence of LMB. As shown in Fig. 3 B, cells
stimulated under Th2-differentiating conditions in the
presence of both TGF-  and LMB showed very little evi-
dence of nuclear trapping by LMB compared with control
stimulated cells that were treated with LMB suggesting
that TGF-  interfered with a signaling event that controls
NFATc import (dephosphorylation).
One key check point in the initiation and maintenance
of nuclear presence of NFATc is calcium (Ca2 ) influx in
cells (37, 38). We reasoned that if Ca2  influx into cells was
affected by the presence of TGF- , then we should be able
to bypass the effects of TGF-  by addition of a calcium
ionophore such as ionomycin to the cells. CD4  T cells
were stimulated with phorbol myristate acetate (PMA) and
ionomycin under Th2-stimulatory conditions in the pres-
ence or absence of TGF-  and the expression of NFATc
and GATA-3 was analyzed. As illustrated in Fig. 3 C,
TGF-  did not inhibit the nuclear presence of NFATc or
of GATA-3 when cells were treated with PMA and iono-
mycin indicating that TGF-  targeted pathways that regu-
lated [Ca2 ]i levels.
To assess the importance of inhibited NFATc1 on T cell
differentiation by TGF- , a constitutively active mutant
form of NFATc1 or control virus was introduced into
CD4  T cells by retroviral-mediated gene transfer tech-
niques (21). As shown in Fig. 3 D, infection of cells with
virus expressing the mutant but not with the control virus
restored GATA-3 expression in the cells. It is interesting
that this mutant was found to increase IFN-  expression
and actually decrease IL-4 expression in recent studies (21).
However, as shown in Fig. 3 D, the levels of the cytokine
IL-13 in the culture supernatant was restored to levels in
the absence of TGF-  when caNFATc1 was expressed in
the presence of TGF- . Similarly, we have also found sig-
nificant restoration of IL-5 levels (unpublished data). It
should be noted that since TGF-  was added to the cul-
tures after infection with retrovirus to allow efficient infec-
tion with the virus, the inhibition of IL-13 production by
TGF-  was not as drastic as shown in Figs. 1 and 2 where
TGF-  was present since the beginning. Given its ability to
restore GATA-3 expression and maintain IL-5 and IL-13
expression, the effect of caNFATc1 on IL-4 could be spe-
cific and suggests that while NFATc1 is undoubtedly im-
portant for IL-4 expression as previous studies have shown
(29, 30), unregulated expression of NFATc1 may ulti-
mately inhibit IL-4 expression by conflicting with the ex-
pression of or antagonizing other transcription factors such
Figure 3. TGF-  interferes with signals essential for NFATc transloca-
tion but not gene expression. In all experiments (A) whole cell lysates were
prepared from CD4  T cells stimulated under Th2 differentiating condi-
tions in the presence or absence of TGF-  or CsA. The expression of
NFATc was assessed by immunoblotting. (B) CD4  T cells were in-
cubated with or without leptomycin B (20 ng/ml) for 30 min and then
stimulated with anti-CD3 and anti-CD28 under Th2 differentiating con-
ditions   TGF-  (50 pM). Nuclear extracts were prepared after 4 h of
stimulation and analyzed for the presence of NFATc. (C) CD4  T cells
were stimulated with PMA and ionomycin under Th2 differentiating con-
ditions with or without the addition of TGF-  (50 pM). Nuclear extracts
were prepared and analyzed for the presence of NFATc and GATA-3. It is
to be noted that while stimulation by Ag   APC or anti-CD3   anti-
CD28 maintains nuclear presence of NFATc up to 5 d, very little ac-
tive NFATc is detected at 5 d after stimulation with a combination of
PMA and ionomycin. (D) Expression of constitutively active NFATc
(caNFATc1) in CD4  T cells restores the expression of GATA-3 and IL-
13 inhibited by TGF- . Activated CD4  T cells were infected with re-
combinant retrovirus expressing caNFATc1 and or control virus. Infected
CD4  T cells were subsequently incubated under Th2-differentiating
condition with or without TGF-  (50 pM). Nuclear extracts were pre-
pared at 5 d of culture and analyzed by immunoblotting for the presence of
GATA-3. The same blot was then stripped and reprobed with anti-Oct-1
antibody. Culture supernatants were analyzed for the presence of IL-13.T
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as c-maf that are important for IL-4 gene transcription but
not for IL-5 or IL-13 expression (39).
TGF-  Does Not Prevent Th2 Responses in Committed Th2
Cells. To investigate whether TGF-  was also able to in-
fluence Th2 responses in already committed Th2 cells
which have high levels of GATA-3 expression, we allowed
CD4  T cells to differentiate along the Th2 lineage with-
out TGF-  and added it only during restimulation. As
shown in Fig. 4, addition of TGF-  during secondary
stimulation did not impair either GATA-3 or NFATc ex-
pression or Th2 cytokine production. This shows that
TGF-  can prevent the development of Th2 cells but does
not affect activation of already committed Th2 cells. Our
results are not unexpected since it has been previously
shown that T cells developing along the Th2 lineage un-
dergo loss of calcium signaling pathways (40) and thus
these cells can be expected to be less susceptible to inhibi-
tion by TGF- .
TGF-  Affects Th1 Development by Inhibiting Both T-bet
and NFATc Expression. Although TGF-  has been shown
to affect Th1 development (41, 42), given the IFN- –stim-
ulating effect of the constitutively active NFATc and the
demonstrated role of NFATc in IFN-  gene transcription
(43, 44), we were interested to determine whether TGF- 
was able to inhibit NFATc activation in Th1-developing
cells. As shown in Fig. 5 A, while TGF-  did inhibit T-bet
expression as shown previously, the effect on NFATc was
more pronounced. These inhibitory effects were reflected
in inhibition of IFN-  production by the cells (Fig. 5 B).
TGF-  Interferes with Activation of the Tec Kinase Itk.
Stimulation of the TCR/CD28 signaling pathways results
in a complex series of sequential phosphorylation/dephos-
phorylation events that control cell proliferation and differ-
entiation. The Tec family of nonreceptor tyrosine kinases
has an important role in integrating multiple signals from
TCR/CD28 and transmitting them to molecules down-
stream in the signaling cascade. In T cells, three Tec-family
members have been well studied: Itk, Rlk, and Tec (45).
Both TCR signaling and costimulatory signals contribute
to tyrosine phosphorylation of these kinases resulting in
their activation (45). Tec kinases such as Itk and Tec have
been demonstrated to play a role in TCR signaling for IL-2
production, Ca2  mobilization and in turn NFATc translo-
cation (46–48). To determine if TGF-   could interfere
with Itk activity, Itk was immunoprecipitated with anti-Itk
antibody after stimulation of CD4  T cells in the presence
or absence of TGF-  and Itk phosphorylation was analyzed
by immunoblotting with anti-phosphotyrosine antibody.
As shown in Fig. 6 A, Itk phosphorylation was rapidly in-
duced when cells were stimulated by cross-linking of cell
surface-bound anti-CD3 and anti-CD28. The phosphory-
lation peaked at 2 min and was detected until 20 min after
stimulation (unpublished data). When cells were stimulated
with plate-bound antibodies, the increased phosphorylation
was sustained until 60 min after TCR/CD28 stimulation in
the absence of TGF- . Itk phosphorylation, however, did
Figure 4. TGF-  does not in-
hibit Th2 cytokine production
when added during secondary
stimulation of already committed
Th2 cells. (A) CD4  T cells
were stimulated with anti-CD3
and anti-CD28 under Th2 dif-
ferentiating conditions. After 5 d
of culture, cells were harvested
and restimulated with anti-CD3
and anti-CD28 (IL-2, 50 U/ml)
in the presence or absence of
TGF-  (50 pM). Nuclear extracts
were prepared 2 d after restimula-
tion and analyzed by immuno-
blotting with antibodies to
GATA-3 and NFATc. (B) Su-
pernatants were harvested after
48 h and assayed for the produc-
tion of IL-4, IL-5, and IL-13 by
ELISA.
Figure 5. Inhibition of Th1 differentiation by TGF- . (A) CD4  T
cells were stimulated with anti-CD3 and anti-CD28 under Th1 differen-
tiating conditions   TGF-  (50 pM). Nuclear extracts were prepared at
3 d and 5 d of culture and analyzed for the presence of T-bet. The same
blot was then stripped and sequentially reprobed with anti-NFATc anti-
body and anti-CREB-1 antibody. (B) IFN-  concentrations in the cul-
ture supernatants collected at days 2 and 5 after stimulation were deter-
mined by ELISA.T
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not increase in the presence of TGF-  using either method
of cell stimulation. We also examined Itk kinase activity in
Th2-differentiating cells in the presence or absence of
TGF-  and found an inhibition of Itk kinase activity in the
presence of TGF-  (Fig. 6 B). Recently, unlike Itk / 
mice which are defective in Th2 responses in vivo, Itk / 
Rlk /  mice were found to maintain Th2 responses (49).
To investigate Rlk phosphorylation in Th2 developing
cells, Rlk was immunoprecipitated and an immunecom-
plex kinase assay was performed to detect autophosphoryla-
tion of Rlk as described previously (17). As shown in Fig. 6
C, we detected basal levels of phsophorylation of Rlk
which did not change upon stimulation of cells. In other
experiments, this protein band was not detected using con-
trol rabbit serum confirming the specificity of the antise-
rum (unpublished data). Because Itk has been shown to
regulate Ca2  mobilization, which is critical for NFATc
translocation, we next examined the Ca2  response in the
presence of TGF- .
To determine the effects of TGF-  on Ca2  flux in acti-
vated CD4  T cells, we used both flow cytometry and
real-time imaging techniques using the Ca2 -binding ratio-
metric dye Fura-2M. In the flow cytometry method, cells
were loaded with fluo-3 AM and incubated with anti-CD3
and anti-CD28. Cells were activated by cross-linking the
bound antibodies and the intracellular Ca2  level was mon-
itored by flow cytometry. As shown in Fig. 7 A, in the ab-
sence of TGF- , the typical biphasic response was noted
with an initial rapid increase in [Ca2 ]i that was followed
by a sustained low level of [Ca2 ]i. Addition of TGF- 
caused the initial increase in [Ca2 ]i which dropped to
basal levels by 4 min. We have also monitored [Ca2 ]i in
the cells using a ratiometric technique that is being increas-
ingly used to track T cell dynamics at several levels in vitro
(50). In this technique, Fura-2M–loaded CD4  T cells
were added to anti-CD3 and anti-CD28–coated cham-
bered glass coverslips mounted in a Harvard Systems cul-
ture chamber maintained at 37oC and containing medium
with or without TGF- . Images were collected every 10 s
using motorized excitation filters at 340 and 380 nm and
emission at 515 nm. Images at two time points are shown
in Fig. 7 B. As shown in Fig. 7 C, there was an initial small
change in the ratio in both control and TGF- –treated
cells which returned to baseline by  150 s. However, the
subsequent steady, dramatic increase in the ratio observed
in the control cells due to increased calcium levels in the
cells was not observed in the presence of TGF- .
TGF-  Does Not Affect Lck or ZAP-70 Phosphorylations
but Inhibits ERK Phosphorylation. To determine whether
inhibition of Itk activation was a consequence of inhibition
of Lck and/or ZAP-70 phosphorylation, which are known
to regulate Itk activation (22, 51), cells were stimulated in
the presence or absence of TGF-  and cell extracts were
prepared to examine protein phosphorylations. As shown
in Fig. 8 A, TGF-  did not inhibit either Lck or ZAP-70
phosphorylations. We also investigated whether TGF- 
could alter other TCR-induced signaling events that have
been suggested to regulate NFATc function. T cells defi-
cient in Itk show an inability to activate the mitogen-acti-
vated protein (MAP) kinases ERK1 and ERK2 (52). ERK
phosphorylation induced upon TCR/CD28 ligation was
inhibited by TGF-  (Fig. 8 B). Interestingly, as observed
with Itk phosphorylation, use of plate-bound antibodies for
cell activation resulted in a delayed profile of ERK phos-
Figure 6. Impaired Itk phosphorylation in the presence of TGF- . (A)
CD4  T cells were stimulated either by cross-linking of cell surface-
bound anti-CD3 and anti-CD28 with rabbit anti–mouse antibody or
with plate-bound anti-CD3 and anti-CD28 antibodies   TGF-  (50
pM). Cells were harvested and lysed at the indicated time points. Cell ly-
sates were immunoprecipitated with anti-Itk antibody. The immunopre-
cipitates were analyzed by immunoblotting using anti-phosphotyrosine
antibody (4G10) to detect the level of phosphorylation. The same blot
was then stripped and reprobed with anti-Itk antibody. (B) TGF-  de-
creases Itk kinase activity in stimulated CD4  T cells. CD4  T cells were
stimulated by anti-CD3 and anti-CD28 under Th2 differentiating con-
ditions   TGF-  (50 pM). Equal amounts of cell lysate proteins were
immunoprecipitated with anti-Itk antibody. The kinase reaction was
performed during 15 min with [ -32P] ATP, cold ATP, and the SRC
peptide. The reaction was stopped, blotted onto phosphocellulose paper,
and incorporation was measured. (C) Effect of TGF-  on Rlk autophos-
phorylation. CD4  T cells were stimulated by anti-CD3 and anti-CD28
under Th2 differentiating conditions with or without TGF-  (50 pM).
Equal amounts of cell lysate proteins were immunoprecipitated with anti-
Rlk antiserum. The kinase reaction was performed with [ -32P] ATP and
cold ATP for 15 min. The reaction was stopped by adding SDS-sample
buffer and the samples were subjected to SDS-PAGE. Protein phosphor-
ylation was assessed by autoradiography.T
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phorylation (at  60 min; unpublished data) as has been
previously observed in other studies (53). The JNK MAP
kinase pathway has been shown to inhibit Th2 responses
through phosphorylation of NFATc (54, 55). We therefore
examined whether TGF-  treatment led to increase in
JNK phosphorylation. However, no increase in JNK phos-
phorylation was observed in the presence of TGF- . Yet
another mechanism that regulates shuttling of NFATc be-
tween the cytoplasm and the nucleus is glycogen synthase
kinase-3 (GSK-3). By phosphorylating serine residues
within serine-rich regions and serine-proline repeats in
NFATc, GSK-3 enhances export of NFATc from the nu-
cleus. Thus while a kinase-inactive mutant of GSK-3 has
been shown to slow down nuclear export of NFATc, over-
expression of GSK-3 expedites nuclear export of this factor
(56). As TCR engagement leads to phosphorylation of
GSK-3, which inhibits its activity thereby allowing nuclear
localization of NFATc, we investigated whether TGF- 
interfered with GSK-3 phosphorylation which would pre-
vent normal activation of NFATc. Our results show that
TGF-  does not interfere with the phosphorylation status
of GSK-3 in stimulated cells (Fig. 8 B).
Discussion
The immunosuppressive functions of TGF-  are well
recognized. TGF-  has been found to inhibit primary re-
sponses in CD4  T cells during both Th1 and Th2 differ-
entiation and memory Th2 cells were found to resist TGF-
 –mediated suppression (57). In Th1 cells, the inhibitory
effect of TGF-  was initially associated with the attenua-
tion of IL-12R 2 expression and, more recently, with in-
hibition of T-bet expression (41, 42). Consistent with the
reports of two other groups (27, 28), we show inhibition of
Figure 7. TGF-  blocks Ca2  influx in activated CD4  T cells. (A)
Fluo-3 AM loaded CD4  T cells were incubated with anti-CD3 and
anti-CD28 for 15 min on ice. After measuring the basal mean fluores-
cence intensity (mean F0) for 80 s, cells were stimulated by cross-linking
with rabbit anti–mouse antibody in a Hepes-buffered saline solution con-
taining IL-2 (50 U/ml) with or without TGF- . Ca2  flux was moni-
tored by measuring mean fluorescence intensity (F) for the next 10 min.
(B) CD4  T cells were added to the warmed chambered anti-CD3– and
anti-CD28–coated cover-slip containing culture medium and images
were collected every 10 s. The cells are colored to show the relative in-
tensities of the 340 nm (green) and 380 nm (red) signal. At early time
points (for example in the 1 min and 40 s time point shown here), most
cells appear red/orange reflecting the higher 380 nm component to the
signal. However, at later time points (in this example the 8 min 30 s im-
ages are shown), while there is little change in the ratio in cells treated
with TGF- , the control cells show a clear change in the ratio, and most
of the cells have a significant increase in the 340 component (bar   50
microns). (C) Graphical representation of the results. The measured val-
ues represent the ratio for 15 cells in each experimental condition.
Figure 8. TGF-  does not inhibit Lck or ZAP-70 phosphorylations
but inhibits ERK phosphorylation. Whole cell lysates were prepared from
CD4  T cells stimulated by cross-linking anti-CD3 and anti-CD28
bound to cells under neutral conditions (IL-2, 50 U/ml) in the presence
or absence of TGF-  (50 pM). Total cell lysates were prepared and ana-
lyzed for the phosphorylation of (A) Lck and ZAP-70 or (B) ERK, JNK,
and GSK-3.T
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GATA-3 expression in Th2 cells in the presence of TGF- 
and absence of any effects on STAT6 activation. In devel-
oping Th1 cells, TGF-  caused inhibition of IFN-  pro-
duction and T-bet expression as shown previously (42).
Addition of TGF-  during differentiation to either lineage
inhibited NFATc activation. A critical requirement for
NFATc activation is sustained levels of elevated [Ca2 ]i.
We show that TGF-  prevents Ca2  influx in CD4  T
cells that is important for both Th1 and Th2 differentiation.
The phosphorylation of the Tec kinase, Itk, which regu-
lates Ca2  mobilization and NFATc translocation (45, 47,
52, 58) was impaired in the presence of TGF- .
We and others have demonstrated an essential role for
GATA-3 in Th2 differentiation (18, 59). Inhibition of
GATA-3 function in mice limits Th2 responses in a model
of allergic airway inflammation (19). We have also shown
that the p50 subunit of NF- B plays a nonredundant role
in GATA-3 gene expression in developing Th2 cells (12),
most likely involving the classic NF- B complex, the p50:
p65 heterodimer, that is activated by TCR signaling. NF-
 B, however, does not appear to be a target of TGF- . In-
stead our data suggest that the inhibition of GATA-3 ex-
pression by TGF-  may be secondary to inhibition of
NFATc activation by TGF-  since CsA inhibited not only
NFATc translocation but also GATA-3 expression and in-
hibition of a constitutively active mutant of NFATc re-
stored GATA-3 expression and also Th2 cytokine produc-
tion. The precise mechanism by which NFATc controls
GATA-3 expression remains to be determined. It is to be
noted that multiple NFAT-binding sequences can be iden-
tified in the 5 -flanking region of the GATA-3 gene.
Activation of transcription factors such as NF- B and
NFATc, that play crucial roles in orchestrating multiple re-
sponses in T cells including proliferation, differentiation,
and apoptosis, is dependent on Ca2  mobilization. There
are two stages of Ca2  mobilization in T and B cells which
are coupled to differential transcription factor activation
through various signaling intermediates. TCR stimulation
leads to an initial rapid but transient peak of Ca2  influx.
This is triggered by TCR-induced activation of PLC- 
which cleaves phosphatidylinositol 4,5 biphospahate (PIP2)
to inositol 1,4,5-triphosphate (IP3) and diacylglycerol
(DAG). IP3 then binds to IP3 receptors on the endoplasmic
reticulum which triggers release of intracellular stores of
Ca2  into the cytoplasm. This initial rise in [Ca2 ]i then
signals influx of Ca2  across the plasma membrane which is
mediated by specialized depletion-activated channels called
calcium-release-activated Ca2  channels (CRAC; refer-
ence 60). The initial [Ca2 ]i spike is sufficient to activate
NF- B (38). However, other transcription factors such as
NFAT require more sustained [Ca2 ]i levels (37, 38). Our
results show that while TGF-  does not affect the initial
rapid increase in [Ca2 ]i, it compromises the duration of
the Ca2  signal which is consistent with our observation
that the activation of NFAT, but not of NF- B, is affected
by TGF- .
After TCR ligation or engagement of IgM on B cells,
nonreceptor tyrosine kinases including members of the Src
and Syk family are activated by phosphorylation, which in
turn activate another family of kinases, the Tec kinases,
which include Itk/Tsk/Emt, TxK/Rlk, and Tec in T cells
and Btk in B cells which play an important role in transmit-
ting signals that ultimately result in Ca2  mobilization and
appropriate responses in T cells and B cells (17, 47, 52, 61).
It is believed that the Tec kinases are involved in sustained
Ca2  influx through capacitative calcium entry which re-
quires prolonged activation of PLC-  in stimulated lym-
phocytes (46). Gene targeting studies showed that Btk- or
Itk- or Itk/Rlk-deficiency affects PLC-  activation as well
as Ca2  mobilization and MAPK activation after TCR li-
gation despite preservation of normal patterns of tyrosine
phosphorylation and maintenance of the initial rise in
[Ca2 ]i due to release from intracellular stores (46, 52, 58).
The phosphorylation of Itk has been shown to depend on
the activation of both Lck and ZAP70 although Itk does
not appear to be a direct substrate of ZAP-70. As our stud-
ies did not reveal any inhibition of Lck or ZAP70 phos-
phorylation by TGF- , lack of Itk phosphorylation in the
presence of TGF-  may be due to blockade by TGF-  of
Itk recruitment to the membrane complex that is necessary
for Itk phosphorylation and activation. It is also possible
that the kinase that phosphorylates Itk is a more proximal
target of TGF- .
Itk has been shown to be essential for Th2 responses in
vivo (62). However, stimulated CD4  T cells from Itk-
deficient mice are unable to mount Ca2  flux across the
plasma membrane that is essential for NFATc activation
(58). As an increase in [Ca2 ]i is important for both Th1
and Th2 differentiation and the subsequent translocation of
NFATc also appears to be important for both Th1 and Th2
responses, it stands to reason that Itk is important for both
Th1 and Th2 differentiation. By establishing Itk as a target
of TGF- –mediated immunosuppression, our studies
strengthen the importance of Tec kinases in controlling
critical downstream events in T cell differentiation such as
the induction of sustained [Ca2 ]i levels and the nuclear lo-
calization of NFAT. It will be interesting to determine the
precise relationship between proximal signaling events such
as Tec kinase phosphorylation, Ca2  influx and NFATc
and the expression of the transcription factors T-bet in Th1
cells and GATA-3 in Th2 cells.
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